| Pharmaceutical Information |
| Drug Name |
Meclofenamate sodium |
| Drug ID |
BADD_D01363 |
| Description |
A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis. |
| Indications and Usage |
For the relief of mild to moderate pain, for the treatment of primary dysmenorrhea and for the treatment of idiopathic heavy menstrual blood loss. Also for relief of the signs and symptoms of acute and chronic rheumatoid arthritis and osteoarthritis. |
| Marketing Status |
approved; vet_approved |
| ATC Code |
M01AG04; M02AA18 |
| DrugBank ID |
DB00939
|
| KEGG ID |
D00169; D08162
|
| MeSH ID |
D008469
|
| PubChem ID |
4038
|
| TTD Drug ID |
D08IFL
|
| NDC Product Code |
0378-3000; 49452-4397; 22568-1018; 0378-2150; 63126-301 |
| UNII |
94NJ818U2W
|
| Synonyms |
Meclofenamic Acid | Meclofenamate Sodium Anhydrous | Benzoic acid, 2-((2,6-dichloro-3-methylphenyl)amino)-, monosodium salt, monohydrate | Meclofenamate Sodium | Sodium Meclofenamate | Meclofenamate, Sodium | Meclofenamate Sodium Monohydrate | Meclofenamate | Meclomen |
|
| Chemical Information |
| Molecular Formula |
C14H10Cl2NNaO2 |
| CAS Registry Number |
6385-02-0 |
| SMILES |
CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl.[Na+] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
